ISCI/FRM/004 – hES Cell Details Please complete a form for each hES cell line PHOTOCOPY ADDITIONAL FORMS, AS REQUIRED Participating Laboratory: Contact Name: L. Ahrlund-Richter Karolinska Institute Stockholm, Sweden Marta Imreh Dept of Lab. Med. Karolinska Institute 141 57 Stockholm, Sweden E-mail: marta.imreh@ki.se Tel: + 46 8 5858 3641 Cell Line: HS181 CELL LINE DERIVATION: Embryo details 4BB Embryo used (please tick) Fresh Frozen Was the embryo known to carry any mutations? Yes No If so, please provide details: Isolated Inner Cell Mass Was the line derived from whole embryo or isolated inner cell mass (please tick)? ICM isolated by Whole embryo ICM isolated by Mechanical dissociation immunosurgery If immunosurgery, what antibody and complement was used? Rabbit anti Human whole serum (Sigma) Guinea pig complement serum (Sigma) Media used (give details) Knockout D-MEM 13 (GibcoBRL, Life Technologies), supplemented with 2 nmol/l Lglutamine, 20% FCS (R&D, Sweden), 0.1 mmol/l b-mercaptoethanol (Gibco), 1% non-essential amino acids (Gibco), and recombinant human LIF, 1 ml/ml (Chemicon, UK). Feeder cell used (give details Human foreskin fibroblast line; CRL2429 (ATCC) Time to first passage: 1w Subculture method used for first passage: Mechanical SUBSEQUENT CELL LINE MAINTENANCE Feeder cells used (give details): Litt. ref: Imreh, P., Wolbank, S., Unger, C., Gertow, K., Aints, A., Szeles, A., Imreh, S., Hovatta, O., Fried, G., Dilber, S., and Ährlund-Richter, L. Culture and expansion of the human embryonic stem cell line HS181, evaluated in a double color system. Stem Cells and Development Vol. 13:337-343, 2004 The HS181 cells were cultured in 80% KO-Dulbecco’s modified Eagle medium (DMEM) (Invitrogen/Gibco-BRL; PL 10829018), 20% serum replacement/SR (Invitrogen/Gibco-BRL; PL10828028), 2 mM L-glutamine (Invitrogen/Gibco-BRL; 25030024), 1% nonessential amino acids (Invitrogen/Gibco-BRL; 11140035), 0.1 mM beta-mercapoethanol (Invitrogen/Gibco-BRL; 31350010), and 4 ng/ml fibroblast growth factor (bFGF) (Invitrogen/Gibco-BRL; 13256029), Penic./Strept. (Invitrogen/Gibco-BRL; PL 15140122). Human foreskin fibroblast line; CRL2429 (ATCC) Population doubling time, if known 24-36 h Subculture protocol used (give details): Media used (give details): Karyotype of cells – please include passage level(s) at which karyotyping was performed 46XX at passages 22, 32, 39, 45, 54 Has there been any alteration over time in: YES NO 1 (please tick) X Culture conditions X Cell Characteristics 2 X Karyotype X Differentiation X Other If YES, please provide details: 1 Derived using FCS, now passaged using SR 2 Karyotype changes; trisomy 12 (Imreh, M, Gertow, K, Cedervall, J, Unger, C, Holmberg, C, Szöke, K, Csöregh, L, Fried, G, Dilber, S, Blennow, E, and Ährlund-Richter, L. “In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells”. Journal of Cellular Biochemistry 1;99(2):508-16. 2006) Any other comments/information that you think would be useful to this project HS181 at passage numbers 28/29 (time point 1) and 33/34 (time point 2) were used in the current project. Litt.ref. on derivation of HS181. Hovatta, O, Mikkola, M, Gertow, K, Strömberg, A-M, Inzunza, J, Hreinsson, J, Rozell, B, Blennow, E., Andäng, M., Ährlund-Richter, L. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Human Reproduction 18 (7): 1404-1409, 2003 PLEASE CONTINUE ON ANOTHER SHEET OF PAPER, IF REQUIRED